HomeTOP STORIESKorro Bio gets Orphan Drug Designation from FDA for its genetic disorder... Korro Bio gets Orphan Drug Designation from FDA for its genetic disorder treatment By rogerjudd March 14, 2025 FacebookTwitterPinterestWhatsApp Post Content Previous articleCharles Schwab’s client assets reach $10.28T as of February-end, up 16% Y/Y and down 1% M/MNext articleCardinal Energy reports Q4 results latest articles The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds explore more The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds
